Your practice already holds the answer to its own economics — in the EHR, the billing system, and the buy-and-bill drug ledger where your real margin moves. Eyenstein brings it together into intelligence you can trust, so a $5–10M practice operates with the clarity of a modern enterprise.
Angiography reveals where fluid escapes in a diseased retina. Eyenstein applies the same discipline to your finances. Select an area to see where a $5–10M practice commonly loses margin it has already earned.
Not another dashboard nobody opens. A specialist who understands retinal healthcare data, finds what's buried, makes it legible, and turns it into decisions you can act on.
Every source that touches revenue — EHR, practice management, billing, drug purchasing, imaging, scheduling — mapped and reconciled, so the numbers your systems keep apart finally sit together.
A unified, secure practice warehouse feeds clean dashboards and the monthly report owners actually read: margin, volume, AR, payer mix and physician productivity in one trusted place.
Predictive models built on your own history — forecasting drug spend, scoring denial risk before write-off, and anticipating demand — so you decide ahead of the numbers, not after them.
Built from your data, in your language — J-codes, buy-and-bill, referrals, chair time. Not generic healthcare BI bolted onto a retina practice.
True margin on every anti-VEGF injection — acquisition vs ASP+6%, JW/JZ wastage, biosimilar switching, per-payer spread — by drug, physician, and site.
The page owners open first: revenue, drug spend & margin, injection volume, AR, payer mix and physician productivity in one trusted readout.
Denials grouped by CARC/RARC and root cause, dollars at risk aged past 90 days, and a worklist that tells your team exactly what to rework first.
Injections, procedures, imaging and RVUs per physician and per chair-hour across every location — so you see who and what drives the practice.
Reimbursement by payer measured against contracted rates, with underpayments surfaced automatically before they're accepted as normal.
For a referral-based group: where referrals originate, how they convert, and where they quietly lapse — the growth lever most practices fly blind on.
Forecasts built on your own history — drug spend, denial risk and demand — so you plan against what's coming instead of reconciling what already happened. Modeling grounded in retina, not a generic engine.
A focused engagement with one senior specialist. No RFP, no six-figure platform license, no year-long implementation.
I map every system that touches revenue and quantify where margin is slipping — measured against your actual numbers.
Your sources are unified into one secure, HIPAA-conscious warehouse that stays under your control — the single source of truth.
Your dashboards and monthly report go live for owners, billing and physicians — the numbers everyone trusts, kept current.
Forecasting and denial-risk models go on top of the reporting — and I stay on as the analyst who knows your data.
Large firms send junior staff to learn your business on your time, hand you a platform license, and move on. Eyenstein does the opposite: I already understand retinal healthcare data, I build the exact instrument your practice needs, and I stay close enough to notice when a number looks wrong.
You get the clarity of a modern, AI-enabled enterprise with the accountability of a single name on the account. That is the idea behind Eyenstein — rigorous intelligence, focused entirely on the eye.
A two-week data teardown, quantified against your real numbers. You'll see exactly where the margin is leaking before you commit to anything further.
Book a data teardown